Jeffrey Wong, MD, discusses the unmet needs in prostate cancer treatment, especially in regard to radiopharmaceuticals.

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

A clinical trial reveals that supervised resistance and aerobic exercise can boost sexual function in men with prostate ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

Trisha Goddard’s appearance on Celebrity Big Brother while undergoing palliative treatment for stage 4 metastatic breast ...

• Ultra-low PSA Response (<0.02 ng/mL) with Darolutamide Plus ADT in ARANOTE Correlates with Greatly Improved Clinical Outcomes Interactive Poster Session: IP26-07; April 29, 9:30-11:30 a.m. PDT ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Sexual function data support enzalutamide as monotherapy and combined with leuprolide in patients with high-risk biochemically recurrent prostate cancer. Enzalutamide monotherapy maintains sexual ...

The first patient in a phase 2 clinical trial evaluating 67Cu-SAR-bisPSMA for patients with metastatic castration-resistant ...

Radiotherapy remains a fundamental treatment for prostate cancer, and recent developments in precision medicine and ...